These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12164652)

  • 21. Salivary basic proline-rich proteins are elevated in HIV-exposed seronegative men who have sex with men.
    Burgener A; Mogk K; Westmacott G; Plummer F; Ball B; Broliden K; Hasselrot K
    AIDS; 2012 Sep; 26(15):1857-67. PubMed ID: 22824632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
    Skott P; Lucht E; Ehnlund M; Björling E
    Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of human beta-defensins in HIV infection.
    Weinberg A; Quiñones-Mateu ME; Lederman MM
    Adv Dent Res; 2006 Apr; 19(1):42-8. PubMed ID: 16672548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary and mucosal immune responses to HIV and its co-pathogens.
    Challacombe SJ; Sweet SP
    Oral Dis; 1997 May; 3 Suppl 1():S79-84. PubMed ID: 9456663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate immunity including epithelial and nonspecific host factors: workshop 1B.
    Weinberg A; Naglik JR; Kohli A; Tugizov SM; Fidel PL; Liu Y; Herzberg M
    Adv Dent Res; 2011 Apr; 23(1):122-9. PubMed ID: 21441493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners' viral load.
    Hasselrot K; Bratt G; Hirbod T; Säberg P; Ehnlund M; Lopalco L; Sandström E; Broliden K
    AIDS; 2010 Jan; 24(1):35-43. PubMed ID: 19779318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (C3) The oral epithelial cell and first encounters with HIV-1.
    Herzberg MC; Weinberg A; Wahl SM
    Adv Dent Res; 2006 Apr; 19(1):158-66. PubMed ID: 16672567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
    Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
    Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing of anti-HIV antibodies in saliva.
    Chassany O; Bergmann JF; Mazeron MC; Cervoni J; Grégoire V; Sanson-Le-Pors MJ; Caulin C
    AIDS; 1994 May; 8(5):713-4. PubMed ID: 8060558
    [No Abstract]   [Full Text] [Related]  

  • 30. Saliva and salivary gland alterations in HIV infection.
    Fox PC
    J Am Dent Assoc; 1991 Nov; 122(11):46-8. PubMed ID: 1686879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modified ELISA and western blot accurately determine anti-human immunodeficiency virus type 1 antibodies in oral fluids obtained with a special collecting device.
    Emmons WW; Paparello SF; Decker CF; Sheffield JM; Lowe-Bey FH
    J Infect Dis; 1995 Jun; 171(6):1406-10. PubMed ID: 7769274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.
    Freel SA; Fiscus SA; Pilcher CD; Menezes P; Giner J; Patrick E; Lennox JL; Hicks CB; Eron JJ; Shugars DC
    AIDS; 2003 Sep; 17(14):2025-33. PubMed ID: 14502005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of sensitivity and specificity of first, second, and third generation EIA for the detection of antibodies to HIV-1 in oral fluid.
    Louie B; Lei J; Liska S; Dowling T; Pandori MW
    J Virol Methods; 2009 Jul; 159(1):119-21. PubMed ID: 19442855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 exposed uninfected men who have sex with men have increased levels of salivary CC-chemokines associated with sexual behavior.
    Hasselrot K; Bratt G; Duvefelt K; Hirbod T; Sandström E; Broliden K
    AIDS; 2010 Jun; 24(10):1569-75. PubMed ID: 20549845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and salivary IgG subclasses in HIV type 1 infection: evidence of both transudation and local synthesis of IgG in parotid saliva.
    Wu X; Jackson S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1423-31. PubMed ID: 11018862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.
    Cummins JE; Christensen L; Lennox JL; Bush TJ; Wu Z; Malamud D; Evans-Strickfaden T; Siddig A; Caliendo AM; Hart CE; Dezzutti CS
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):788-95. PubMed ID: 16910835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
    Wahl SM; McNeely TB; Janoff EN; Shugars D; Worley P; Tucker C; Orenstein JM
    Oral Dis; 1997 May; 3 Suppl 1():S64-9. PubMed ID: 9456660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological and molecular detection of human immunodeficiency virus in saliva, and comparison with blood testing.
    Yapijakis C; Panis V; Koufaliotis N; Yfanti G; Karachalios S; Roumeliotou A; Mantzavinos Z
    Eur J Oral Sci; 2006 Jun; 114(3):175-9. PubMed ID: 16776764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate Immunity and Saliva in Candida albicans-mediated Oral Diseases.
    Salvatori O; Puri S; Tati S; Edgerton M
    J Dent Res; 2016 Apr; 95(4):365-71. PubMed ID: 26747422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral dynamics of early HIV infection in neonatal macaques after oral exposure to HIV-2287: an animal model with implications for maternal-neonatal HIV transmission.
    Herz AM; Robertson MN; Lynch JB; Schmidt A; Rabin M; Sherbert C; Agy MB; Anderson D; Hu SL; Greenberg PD; Morton WR
    J Med Primatol; 2002 Feb; 31(1):29-39. PubMed ID: 12076046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.